ARS Pharmaceuticals, Inc. (SPRY) Net income 2020–2025
ARS Pharmaceuticals, Inc. (SPRY) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$171.3MFY2025 · since FY2020: -$32.9M → -$171.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$171.3M | -2241.8% |
| FY2024 | $8.0M | +114.7% |
| FY2023 | -$54.4M | -56.8% |
| FY2022 | -$34.7M | -71.3% |
| FY2021 | -$20.2M | +38.6% |
| FY2020 | -$32.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice